Abstract:A series of biological barriers in a nanoparticle-formulated drug delivery process inevitably result in the current low delivery efficiency, limited tumor penetration and insufficient cellular internalization of drugs. These multiple biological barriers are intimately related to the physicochemical properties of nanoparticles, especially the contradictory demand on size and surface charge for long blood circulation (larger and negative) and deep tumor penetration (smaller) as well as efficient cellular internalization (positive). Herein, we report tumor microenvironment triggered size and charge dual-transformable nanoassemblies. The nanoassembly is realized by immobilizing positive up/downconverting luminescent nanoparticles (U/DCNPs) onto large mesoporous silica nanoparticles (MSNs) via acid-labile bonds to form core@satellite structured MSN@U/DCNPs nanoassemblies, and subsequent capping of charge reversible polymers. At physiological pH, the integrated nanoassemblies with a larger size (∼180 nm) and negative charge can effectively achieve a prolonged blood circulation and high tumor accumulation. While under an acidic tumor microenvironment, the charge reversal of outer polymers and cleavage of linkers between MSNs and U/DCNPs can induce disintegration of the nanoassemblies into isolated MSNs and smaller U/DCNPs, both with a positively charged surface, which thereby potentiate the tumor penetration and cell uptake of dissociated nanoparticles. Combined with the independent near-infrared (NIR)-to-visible and NIR-to-NIR luminescence of U/DCNPs and high surface area of MSNs, the nanoassemblies can implement NIR bioimaging guided chemo- and photodynamic combined therapy with remarkable antitumor efficiency because of the high accumulation and deep tumor penetration induced by the dual transformability of the nanoassemblies.

Charge-reversal Nanomedicines As a Smart Bullet for Deep Tumor Penetration

Charge-reversal nanocarriers: An emerging paradigm for smart cancer nanomedicine

Charge-reversal nanoparticles: novel targeted drug delivery carriers

“Smart” Nanocarriers: A New Paradigm for Tumor Targeting Drug Delivery Systems

Pt/DOX Nanomotors Enhance Penetration in the Deep Tumor by Positive Chemotaxis

Applications of Surface Modification Technologies in Nanomedicine for Deep Tumor Penetration

Barrier permeation and improved nanomedicine delivery in tumor microenvironments

Recent Advances in Drug Delivery Systems for Enhancing Drug Penetration into Tumors

Mechanisms, Challenges, and Therapeutic Applications

Size and Charge Dual-Transformable Mesoporous Nanoassemblies for Enhanced Tumor Delivery and Penetration

Strategies to improve tumor penetration of nanomedicines through nanoparticle design

Size and Charge Dual-Transformable Mesoporous Nanoassemblies for Enhanced Drug Delivery and Tumor Penetration.

Advances in 2,3-Dimethylmaleic Anhydride (DMMA)-Modified Nanocarriers in Drug Delivery Systems

Size Shrinkable Drug Delivery Nanosystems and Priming the Tumor Microenvironment for Deep Intratumoral Penetration of Nanoparticles

Smart and bioinspired systems for overcoming biological barriers and enhancing disease theranostics

Intelligent Responsive Nanoparticles with Multilevel Triggered Drug Penetration for Tumor Photochemotherapy

Targeted Charge-Reversal Nanocarriers for Nuclear Drug Delivery

Aminopeptidase N-Responsive Conjugates with Tunable Charge-Reversal Properties for Highly Efficient Tumor Accumulation and Penetration

A novel strategy based on a ligand-switchable nanoparticle delivery system for deep tumor penetration

A light-driven dual-nanotransformer with deep tumor penetration for efficient chemo-immunotherapy

Recent Advances in Nanostrategies Capable of Overcoming Biological Barriers for Tumor Management